Almirall profit quadruples in 2025 as dermatology fuels growth push
Almirall, a pharmaceutical firm based in Spain, ended 2025 with a net profit of €46.2 million, which was 357% more than its 2024 profit of €10.1 million. The Barcelona-based pharmaceutical company was able to exceed the significant €1 billion sales threshold thanks to a 12.5% increase in revenue to €1.1145 billion. Following a more muted
